Clinical Trials Directory

Trials / Completed

CompletedNCT00881803

Iron & Vitamin C Study

Implications of Concurrent Iron and Ascorbic Acid Supplementation on Iron Status in Persons With Spinal Cord Injury

Status
Completed
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
US Department of Veterans Affairs · Federal
Sex
Male
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

Iron overload is a life-threatening condition that can lead to liver disease, cardiac disease, diabetes and arthritis. Simultaneous supplementation with both iron and AA may place individuals with SCI at risk for iron overload as well as oxidative damage by iron-generated free radicals. Both conditions of high and low iron stores may present with common signs and symptoms. Accurate diagnosis of iron disorder should consider CRP, hematocrit, hemoglobin, serum iron, TIBC, percent saturation of iron binding capacity, serum ferritin and hepcidin. The investigators are proposing a study to determine the effect of concurrent AA and iron supplementation on iron status of individuals with SCI. The investigators goal is to identify abnormal status that may be attributed to simultaneous supplementation of iron and AA to develop future supplementation protocols in this population for optimal iron status.

Conditions

Timeline

Start date
2008-06-01
Primary completion
2010-12-01
Completion
2011-06-01
First posted
2009-04-15
Last updated
2012-05-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00881803. Inclusion in this directory is not an endorsement.